Sonida Senior Living, Inc.

NYSE:SNDA

Medical - Care Facilities

Healthcare
$32.42 +1.12%

+$0.39 today

Market cap
$1.59B
Beta
0.78
P/E (TTM)
-6.4
EPS (TTM)
-$5.49
52W Low $23.66High $39.66

Volume 0.50M

Average 0.64M

SNDA Common Stock Issued

Cash raised by issuing new shares.

Sonida Senior Living, Inc.NYSE: SNDA

Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026

Common stock issued outflow grows to $108.78M

Q1 FY2026 common stock issued was $108.78M, compared with $0 a year earlier. Trailing-twelve-month common stock issued was $108.78M.

Context

  • Common stock issued amounted to 0.0% of revenue in FY2025, down 62.6 pp from a year earlier.
  • Common stock issued increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly common stock issued holds near $108.78M or moves back toward the trailing-twelve-month quarterly average of $27.2M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$108.78M— QoQ
Last fiscal yearDec 2025
$0-100.0% YoY
LTMMar 2026
$108.78M-23.9% YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Issued history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
-100.0%

Common Stock Issued vs competitors

How SNDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock issued is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -23.9% is the lowest of 7, against a peer median of +97.2%.
  • Common stock issued amounts to 26.4% of revenue for SNDA, versus a peer median of 0.4%.
SNDA Competitors
Common Stock Issued for SNDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CMPSCOMPASS Pathways plcLTM Mar 2026$344.14M USD+145.2%+584.4%—
FULCFulcrum Therapeutics, Inc.LTM Mar 2026$168.69M USD+15305.3%+27.8%—
SNDASonida Senior Living, Inc.LTM Mar 2026$108.78M USD-23.9%—26.4%
OCGNOcugen, Inc.LTM Mar 2026$56M USD+49.1%-32.5%1254.3%
TOIThe Oncology Institute, Inc.LTM Mar 2026$16.49M USD+7.3%—3.0%
VREXVarex Imaging CorporationLTM Apr 2026$3.3M USD——0.4%
ANGOAngioDynamics, Inc.LTM Feb 2026$950K USD+6.1%—0.3%
LABStandard BioTools Inc.LTM Mar 2026$824K USD+1111.8%—1.0%
SYSo-Young International Inc.LTM Dec 2025CN¥79K CNY——0.0%
CYHCommunity Health Systems, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding SNDA) —+97.2%+27.8%0.4%

Competitors are the stored peer set for SNDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income125.61M(54.4M)(21.11M)(3.28M)(72.49M)
Depreciation & Amortization37.87M38.45M39.89M44.05M56.77M
Deferred Income Tax00000
Stock-Based Compensation2.81M4.33M2.75M4.37M5.05M
Change in Working Capital(8.54M)3.22M13.78M(7.22M)12.85M
Accounts Receivables585K(2.35M)(3.25M)(13.54M)(2.98M)
Inventory00000
Accounts Payables(2.66M)0000
Other Working Capital(6.47M)5.57M17.03M6.32M15.83M
Other Non-Cash Items(186.54M)5.83M(24.63M)(39.7M)22.19M
Operating Cash Flow(28.8M)(2.58M)10.68M(1.78M)24.36M
Capital Expenditures(10.44M)(24.56M)(17.94M)(25.17M)(33.28M)
Acquisitions (Net)0(12.34M)0(184.38M)(37.4M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities001.38M631K0
Investing Cash Flow(10.44M)(36.9M)(16.56M)(208.92M)(70.69M)
Debt Repayment(41.89M)(14.23M)(13.8M)44.01M44.76M
Common Stock Issued113.54M010M190.54M0
Common Stock Repurchased00000
Dividends Paid0(2.99M)0(2.82M)(5.64M)
Other Financing Activities(13.48M)(5.44M)(3.31M)309K(1.62M)
Financing Cash Flow99.42M(22.65M)(7.11M)232.04M37.51M
Effect of Forex Changes00000
Net Change in Cash60.18M(62.13M)(12.99M)21.34M(8.82M)
Free Cash Flow(39.24M)(27.14M)(7.26M)(26.95M)(8.92M)

Sonida Senior Living, Inc.

NYSE:SNDA

Intrinsic Alpha fair value

Locked

Current Price

$32.42

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.